iSpecimen Inc. announced an 85% reduction in human biospecimen shipping times through a new direct-to-customer model, improving logistics efficiency and customer satisfaction.
Key takeaways
Implemented streamlined shipping model enabling direct shipments from suppliers to customers domestically and internationally.
Reduced domestic transit times from 7–14 days to 1–2 days, achieving 70–85% improvement.
Lowered overall shipping costs via fewer handoffs and simplified logistics.
Expanded partnerships in Europe and Eastern Europe for rare biospecimens with better consistency.
Positive customer feedback on speed, reliability, and handling since implementation earlier in 2026.
CEO Katie Field highlighted operational flexibility alongside AI agent advancements.